Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator class drugs

1 result
Marinus Pharmaceuticals, Inc.
Usage: ZTALMY is indicated for treating seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) in patients aged 2 years and older.